2026. EVALUATION OF THE ROLE OF FECAL CALPROTECTIN AS A BIOMARKER OF ENDOSCOPIC DISEASE ACTIVITY IN PATIENTS WITH CROHN’S DISEASE . Global Journal of Public Health Medicine. 8, 1 (Ongoing) (Sep. 2026), 216–227. DOI:https://doi.org/10.37557/33f44713.